Samsung Medical Center
No hidden fees – just official clinic prices. Pay at the clinic for Lymphangioma treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Lymphangioma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Lymphangioma treatment journey.
The doctor is a vascular surgeon with a specialization in stem cell therapy for heart disease. After completing medical education at Hanyang University, the doctor furthered professional expertise as a Visiting Professor in the Department of Vascular Surgery at Oregon Health Sciences University in 2002. From 2017 to 2019, the doctor served as the Head of the Department of Blood Vessel Surgery at Samsung Medical Center, showcasing leadership and advanced clinical skills in vascular surgery.
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
The doctor is a prominent figure in the field of surgery, holding leadership roles such as Director of the Training and Education Committee at the Korean Surgical Society and Director of the Information Technology Committee at the Korean Society of Coloproctology. The doctor also serves as Director of the Surgical Affairs Board at the Korean Society of Gastroenterology and Vice President of the Korean Association of Robotic Surgeons.
With a robust educational background from Korea University, the doctor has demonstrated surgical expertise internationally, including at the Faculty of Medicine, Chinese University of Hong Kong, and Tan Tock Seng Hospital in Singapore.
Samsung Medical Center, Seoul National University Bundang Hospital, and Asan Medical Center are leading institutions for lymphangioma treatment. These facilities hold JCI or KOIHA accreditations and feature multidisciplinary teams. They provide advanced interventional radiology, pediatric surgery, and robotic-assisted procedures for complex vascular malformations.
Bookimed Expert Insight: Patient data shows a clear advantage in choosing Seoul-based tertiary hospitals for lymphangioma. Asan Medical Center and Samsung Medical Center serve millions of patients yearly. These high-volume centers provide integrated care and coordinate interventional radiology with plastic surgery. This prevents fragmented treatment for recurrent lesions.
Patient Consensus: Patients emphasize finding a hospital where radiologists and surgeons work together. They note that having access to both sclerotherapy and surgery in one location is vital for success.
Korean medical centers treat lymphangioma using minimally invasive sclerotherapy and precise surgical excision. Specialized clinics in Seoul utilize advanced sclerosants like OK-432 (Picibanil) and Bleomycin. These methods achieve response rates above 75% for complex head and neck lymphatic malformations in children and adults.
Bookimed Expert Insight: Korea ranks 7th globally in our medical market data for highly specialized care. Severance Hospital alone serves over 4,000,000 patients annually. This massive volume means Korean specialists manage rare vascular malformations far more frequently than doctors in many Western countries. Such high-frequency exposure lead to refined protocols that balance aesthetic results with complete lesion removal.
Patient Consensus: Patients note that multiple sclerotherapy sessions are often necessary for full resolution. Many emphasize choosing Seoul-based hospitals to ensure access to the latest sclerosant medications and pediatric surgical expertise.
Sclerotherapy is the standard first-line treatment for lymphangioma in South Korea because it is minimally invasive. Surgeons may perform immediate surgery for large lesions causing urgent functional issues like breathing or swallowing difficulties. Well-defined, accessible cysts often favor direct surgical removal over repeated injections.
Bookimed Expert Insight: Data from top-tier Seoul centers like Asan Medical Center and Samsung Medical Center show a trend toward hybrid planning. While Asan Medical Center performs over 65,000 surgeries annually, their specialists often use sclerotherapy to shrink a mass first. This reduces the surgical field. Even at digital-advanced facilities like Seoul National University Bundang Hospital, doctors emphasize that complete removal in one operation is rare for complex cases.
Patient Consensus: Patients note that treatment is rarely a single event. Many emphasize asking doctors if a lesion is macrocystic or microcystic before agreeing to the first procedure.
Medical tourists can verify a Korean physician expertise by confirming affiliation with major tertiary centers like Asan Medical Center. Ensure the doctor follows International Society for the Study of Vascular Anomalies (ISSVA) standards. Specialists must participate in multidisciplinary teams involving interventional radiology and plastic surgery.
Bookimed Expert Insight: Korea leading hospitals operate at an immense scale. Asan Medical Center treats over 11,000 outpatients daily. This volume suggests that specialists there likely see more rare vascular anomalies in a month than many Western doctors see in a year. When choosing a specialist, look for those affiliated with these high-volume academic institutions. Their access to diverse clinical cases and internal peer review ensures higher diagnostic accuracy.
Patient Consensus: Patients emphasize checking if a doctor focuses on medical lymphangioma rather than aesthetic vein treatments. They also suggest requesting a written treatment plan before traveling to confirm the doctor uses clinical imaging rather than just visual exams.
International patients typically remain in South Korea for 2 to 4 weeks for lymphangioma treatment. This allows for diagnostics, the chosen procedure, and safe recovery. Complex surgical excision often requires 3–4 weeks. Minor sclerotherapy might allow for a shorter 14-day stay.
Bookimed Expert Insight: While many choose Seoul for its volume, centers like Asan Medical Center report a 90% success rate in complex cases. Large hospitals like Samsung Medical Center serve over 2,000,000 patients annually. This massive scale often results in faster diagnostic turnaround for international visitors.
Patient Consensus: Patients note that staying the full 4 weeks provides peace of mind. Many emphasize that having enough time for follow-up checks prevents stress during the flight home.